N-[(1R)-3-(4-hydroxyphenyl)-1-methylpropyl]-2-(2-phenyl-1H-indol-3-yl)acetamide

N‑[(1R)‑3‑(4‑hydroxyphenyl)‑1‑methylpropyl]‑2‑(2‑phenyl‑1H-indol‑3‑yl)acetamide is a synthetic small molecule compound with the molecular formula C₂₆H₂₆N₂O₂ and a molecular weight of approximately 398.20 g/mol[5][6][8]. Its structure features an indole moiety linked to an acetamide group, with a hydroxyphenyl substituent on a butan chain[3][6]. The compound is listed in chemical databases such as DrugBank (DB07991), ChEMBL (CHEMBL391910), and ChemSpider (20581160)[1][6]. There are no known approved medical indications, clinical trials, or regulatory approvals for this molecule[7]. Its mechanism of action, pharmacological activity, and therapeutic potential have not been described in public sources as of June 2025.

Other names

N-[(2R)-4-(4-hydroxyphenyl)butan-2-yl]-2-(2-phenyl-1H-indol-3-yl)acetamide4-(4-Hydroxyphenyl)-2-butanyl]-2-(2-phenyl-1H-indol-3-yl)acetamide1H-Indole–3-acetamide, N–[(1R)–3–(4–hydroxyphenyl)–1–methylpropyl]–2–phenyl–